Hospice Care in Mcallen, TX
9 Hospice found. Showing 1 - 9
 Iph Hospice Care Inc Medicare Approved Location: 1100 E Jasmine Ave Suite 203, Mcallen, Texas 78501 Phone: (956) 682-4234 |
Pax Villa Hospice And Palliative Care Medicare Approved Location: 4513 W. Business Hwy 83, Mcallen, Texas 78502 Phone: (956) 686-4414 |
Gracia Hospice Care Medicare Approved Location: 717 East Esperanza Avenue, Mcallen, Texas 78501 Phone: (956) 661-1177 |
Only Love Hospice Medicare Approved Location: 833 E Esperanza Avenue Suite A, Mcallen, Texas 78501 Phone: (956) 631-0616 |
Superior Hospice Of Mcallen Llc Medicare Approved Location: 2108 S M Street Suite 8c, Mcallen, Texas 78503 Phone: (956) 878-1636 |
Renaissance Hospice & Palliative Care Llc Medicare Approved Location: 308 Lindberg Avenue, Mcallen, Texas 78501 Phone: (956) 682-0500 |
Palli-med Hospice Llc Medicare Approved Location: 817 North Ware Road Suite 4, Mcallen, Texas 78501 Phone: (956) 627-2744 |
Tree Of Life Hospice Llc Medicare Approved Location: 1609 N 6th, Mcallen, Texas 78501 Phone: (956) 994-9602 |
Eternal Serenity Hospice Llc Medicare Approved Location: 500 East Beaumont Suite B2, Mcallen, Texas 78501 Phone: (956) 213-8610 |
News Archive
Unemployment rates in healthcare industry fell slightly to 8.1% in April
Unemployment rates fell slightly to 8.1 percent in April according to newly released figures from the U.S. Bureau of Labor Statistics. Employers added 115,000 workers last month, which is down 39,000 from March and 45,000 shy of the minimum some economists had forecast.
Researchers find breast cancer therapy contributes to early-in-life hip fractures in women
A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatment and common drugs used to treat breast cancer, could be weakening the bones of breast cancer survivors once they hit middle age, leading to hip fractures.
ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from GeoVax, Inc.
Archexin has potential to target and treat multiple life-threatening cancers, finds new study
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
› Verified 9 days ago